Blog

A 2026 systematic review led by Shah Q of Shah Medical Complex and Jonathan Soldera of the University of South Wales analyzed 55 studies to answer a pre…

New Evidence on Treating IBS-C: Meal Timing and Targeted Antibiotics Two recent studies provide concrete data on managing IBS with constipation (IBS-C)

The Overlap Between SIBO and IBS: Diagnosis, Treatment, and Preventing Recurrence Small intestinal bacterial overgrowth (SIBO) and irritable bowel syndr…

Time-Restricted Eating and Targeted Antibiotics: Emerging Tools for IBS-C For individuals with irritable bowel syndrome-constipation (IBS-C), finding ef…

The Overlapping Diagnoses of SIBO and IBS: A Clinical Conundrum Twenty-two percent of patients testing negative for Small Intestinal Bacterial Overgrowt…

Introduction For individuals with constipation-predominant irritable bowel syndrome (IBS-C), finding lasting relief can be a persistent challenge

Clinical Symptoms Fail to Distinguish Between SIBO and Sucrose Malabsorption A 2026 study from Beth Israel Deaconess Medical Center found that 22% of pa…

Functional gastrointestinal disorders like irritable bowel syndrome and small intestinal bacterial overgrowth confound patients and clinicians

Time-Restricted Eating and Targeted Antibiotics Show Promise for IBS-C Constipation Managing constipation-predominant irritable bowel syndrome (IBS-C) o…

Rifaximin Leads in Efficacy and Safety for IBS-D and SIBO, Systematic Review Finds A comprehensive systematic review of 55 clinical studies shows Rifaxi…

Time-Restricted Eating and Targeted Antibiotics: Two Paths Forward for IBS-C Management A 2026 pilot study from Kristiania University College found that…

Rifaximin Reduces IBS-D Symptoms with Fewer Side Effects Than Other Antibiotics Systematic review evidence from 55 studies shows the antibiotic rifaximi…